UnitedHealthcares bulletin (Table 1) provides a concrete local example: in Massachusetts and New York One Care plans, UHC made Zepbound preferred for weight-loss, removing Wegovy and Saxenda from the preferred list ( [49] )
Check the guide for more details
Learning to distinguish between medication adjustment effects and genuine adverse interactions requires careful symptom tracking: note when symptoms appear, how long they last, and whether they worsen despite stable doses
But GLP-1s arent right for everyone
Yes, many people reach their weight loss goals and maintain them on lower doses like 5 mg or 7.5 mg
D'Souza RW, Francis WR, Andersen ME: Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure